tiprankstipranks
Trending News
More News >
Kineta updates KVA12123 clinical results from ongoing Phase 1/2 VISTA101 study
PremiumThe FlyKineta updates KVA12123 clinical results from ongoing Phase 1/2 VISTA101 study
6M ago
Kineta announces TuHURA Biosciences extends exclusivity agreement for KVA12123
Premium
The Fly
Kineta announces TuHURA Biosciences extends exclusivity agreement for KVA12123
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100